Rights and permissions
About this article
Cite this article
Stenting worth it, but value of abciximab uncertain. Pharmacoecon. Outcomes News 443, 5 (2003). https://doi.org/10.1007/BF03277191
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277191